NCT04852731View on ClinicalTrials.gov

STretch and Myocardial Characterization in Arrythmogenic Mitral Valve Prolapse-2

NARecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Mitral Valve Prolapse
Interventions
PROCEDURE

Cardiac MRI

Injected cardiac MRI

OTHER

Blood collection

Blood collection (including genetics at the inclusion visit)

PROCEDURE

Prolongation of the MRI examination

Prolongation of the MRI examination (4D flow sequence ; about 10 min)

Trial Locations (1)

54511

RECRUITING

Nancy University Hospital, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER